Bollard Group’s Labcorp LH Stock Holding History

Bollard Group’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,011	Closed	-$430K	–	453
2020 Q2	$430K	Buy	+3,011	New	+$417K	0.02%	145

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

MCM

Melvin Capital Management New York $9.86B AUM 16.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bollard Group's LH Position: Q3 2020 in Review

Bollard Group sold out of Labcorp (LH) in Q3 2020, closing a stake of 3,011 shares — an estimated $430K sold.

Bollard Group first reported a position in LH in Q2 2020 and held it in 1 quarter. The position peaked at $430K in Q2 2020. 809 funds tracked by Wall St. Rank hold LH as of Q3 2020.

Bollard Group reported no remaining Labcorp position as of Q3 2020 after selling out during the quarter.
Bollard Group sold 3,011 Labcorp shares in Q3 2020, an estimated $430K.
Bollard Group first reported a position in Labcorp in Q2 2020 and held it in 1 quarter.
Bollard Group's Labcorp position peaked at $430K in Q2 2020.
809 funds tracked by Wall St. Rank held Labcorp as of Q3 2020.

Based on Bollard Group's 13F filing for Q3 2020, filed 12 Nov 2020.